International Journal of Gynecological Cancer

Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany
pp. 1-7(7)
Authors: CHEKEROV,; DENKERT,; BOEHMER,; SUESSE,; WIDING,; RUHMLAND,; GIESE,; MUSTEA,; LICHTENEGGER,; SEHOULI,

Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients
pp. 8-13(6)
Authors: MOLCKOVSKY,; VIJAY,; HOPMAN,; BRYSON,; JEFFREY,; BIAGI,

HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization
pp. 14-21(8)
Authors: ODICINO,; BIGNOTTI,; ROSSI,; PASINETTI,; TASSI,; DONZELLI,; FALCHETTI,; FONTANA,; GRIGOLATO,; PECORELLI,

Carcinosarcoma of the ovary
pp. 22-29(8)
Authors: SILASI,; ILLUZZI,; KELLY,; RUTHERFORD,; MOR,; AZODI,; SCHWARTZ,

p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China
pp. 30-35(6)
Authors: YAN,; NA,; SHAN,; XIAO-WEI,; WEI,; SHU-CHENG,

Short-interfering RNA-mediated silencing of proliferating cell nuclear antigen inhibit proliferation and induce apoptosis in HeLa cells
pp. 36-42(7)
Authors: HAO,; XIN,; NANCAI,; YANXIA,; QIAN,; WEI,; YANDONG,; HANJU,

A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
pp. 43-50(8)
Authors: PATTERSON,; MURUGAESU,; HOLDEN,; SECKL,; RUSTIN,

A feasibility study of low-dose, prolonged oral topotecan in patients with advanced ovarian, fallopian tube, or primary peritoneal serous cancer who have attained a complete clinical response following platinum-based chemotherapy
pp. 51-58(8)
Authors: COMANDER,; CANNISTRA,

Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors
pp. 59-65(7)
Authors: FERREIRA,; CARVALHO,; SOARES,; SIQUEIRA,

Does fecal diversion offer any chance for spontaneous closure of the radiation-induced rectovaginal fistula?
pp. 66-70(5)
Authors: PIEKARSKI,; JERECZEK-FOSSA,; NEJC,; PLUTA,; SZYMCZAK,; SEK,; BILSKI,; GOTTWALD,; JEZIORSKI,

Human papillomavirus type distribution in women from Asia: a meta-analysis
pp. 71-79(9)
Authors: BAO,; LI,; SMITH,; QIAO,

Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix
pp. 80-84(5)
Authors: UNO,; MITSUHASHI,; ISOBE,; YAMAMOTO,; KAWAKAMI,; UENO,; USUI,; TATE,; KAWATA,; ITO,

Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma
pp. 85-89(5)
Authors: MORI,; HOSOKAWA,; KINOSHITA,; WATANABE,; HONJO,

Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions
pp. 90-94(5)
Authors: PRATO,; GHELARDI,; GADDUCCI,; MARCHETTI,; DiCRISTOFANO,; DiCOSCIO,; BEVILACQUA,; GENAZZANI,

Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity
pp. 95-103(9)
Authors: GOODHEART,; JACOBSON,; SMITH,; ZHOU,

Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China
pp. 104-109(6)
Authors: HONG,; YE,; CHEN,; LÜ,; CHENG,; HU,; XIE,

Silent killer of the night: a feasibility study of an outreach well-women clinic for cervical cancer screening in female sex workers in Hong Kong
pp. 110-115(6)
Authors: WONG,; WUN,; CHAN,; LIU,

Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix—a comparison of management and outcome
pp. 116-120(5)
Authors: DALRYMPLE,; VALMADRE,; COOK,; ATKINSON,; CARTER,; HOUGHTON,; RUSSELL,

Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions
pp. 121-127(7)
Authors: YOSHIDA,; SANO,; KANUMA,; OWADA,; SAKURAI,; FUKUDA,; NAKAJIMA,

Assessment of cervical involvement in endometrial carcinoma by hysteroscopy and directed biopsy
pp. 128-131(4)
Authors: ÁVILA,; RUIZ,; CORTABERRIA,; RIVERO,; UGALDE,

p53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study
pp. 132-135(4)
Authors: POMARA,; SALINITRI,; NESI,; MAIO,; MINERVINI,; GAMMAZZA,; FRANCESCA,; CAPPELLO,; SELLI,

Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?
pp. 136-140(5)
Authors: COHN,; PAVELKA,; FRANKEL,; MORRISON,; HAMPEL,; COPELAND,; FOWLER,

Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovaries and uterus of tamoxifen-treated rats
pp. 141-145(5)
Authors: CIRPAN,; TEREK,; ULUKUS,; AKMAN,; KANIT,

Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia
pp. 146-151(6)
Authors: MILAM,; SOLIMAN,; CHUNG,; SCHMELER,; BASSETT,; BROADDUS,; LU,

Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium
pp. 152-158(7)
Authors: ZHOU,; TENG,; SONG,; WU,

Synchronous primary cancers of the endometrium and ovary
pp. 159-164(6)
Authors: CHIANG,; CHEN,; HUANG,; HSIEH,; CHENG,

Omental metastases in clinical stage I endometrioid adenocarcinoma
pp. 165-167(3)
Authors: FUJIWARA,; SAGA,; TAKAHASHI,; OHWADA,; ENOMOTO,; KONNO,; TANAKA,; SUZUKI,

A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component
pp. 168-172(5)
Authors: ABE,; FURUMOTO,; YOSHIDA,; NISHIMURA,; IRAHARA,; KUDO,; SANO,

An ovarian stromal tumor with luteinized cells: an unusual recurrence of an unusual tumor
pp. 172-175(4)
Authors: DUNCAN,; LEE,; ACHESON,; HAMMOND,

Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer
pp. 176-180(5)
Authors: PARK,; LIM,; BAE,; YOO,; SEO,; KANG,

Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature
pp. 181-184(4)
Authors: TABATA,; NISHIURA,; TANIDA,; KONDO,; OKUGAWA,; SAGAWA,

Primary retroperitoneal mucinous cystadenocarcinomas are a distinct entity
pp. 184-188(5)
Authors: TJALMA,; VANEERDEWEG,

Thoracotomy for the management of recurrent vaginal leiomyosarcoma
pp. 188-190(3)
Authors: ANDERSON,; BODURKA,

Multimodal therapy for the initial management of genital embryonal rhabdomyosarcoma in childhood
pp. 190-192(3)
Authors: MAHARAJ,; NIMAKO,; HADLEY,

Vesicouterine ligament contains abundant autonomic nerve ganglion cells: the distribution in histology concerning nerve-sparing radical hysterectomy
pp. 193-198(6)
Authors: KATAHIRA,; NIIKURA,; ITO,; TAKANO,; NAGASE,; MURAKAMI,; YAEGASHI,

Residents' perspectives on surgical training and the resident-fellow relationship: comparing residency programs with and without gynecological oncology fellowships
pp. 199-204(6)
Authors: COHN,; RONEY,; O'MALLEY,; VALMADRE,

Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure?
pp. 205-205(1)

In response to N.N. Mahajan, R.N. Soni, N.L. Gaikwad, K.N. Mahajan: Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure?
pp. 206-207(2)